Fibromyalgia

Fibromyalgia is characterized by widespread musculoskeletal pain, fatigue and disturbed sleep. This investigational drug study evaluates symptoms of fibromyalgia using American College of Rheumatology (ACR) criteria, headset device worn twice daily for 40 minutes each.

Eligible Participants:

Age 18+
Diagnosised with FMS at least 6 months ago
Participants must have minimum of 11 to 18 defined tender points
Participants willing to discontinue medications that may be used to treat fibromyalgia
Participants do NOT have any other painful, significant, or unstable medical conditions

Exclusion: other painful disorders (including migraines, rheumatic dz); or significant disorders (seizures, major depression, CA, personality disorder, unstable psychological conditions); hearing aids; metal or electrical implanted devices above mid-torso; receiving or applying for disability insurance related to FMS

Contact PainPathways for more information on this research trial at 336.714.8389

For more information about other current government research trials, visit www.clinicaltrials.gov. A service of the U.S. National Institutes of Health